Metraipolis › archive › dc_d9145697a210
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3… — Europe PMC PMID:41257453
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41257453
- DOI
- 10.1002/clt2.70121
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:58:45.828Z
- SHA-256 of the archived text
f574ef32ec98e4342ec3c6f3378abc3edcd358890a54dd3a9167a1a8a4b306b6- Stable URL of this page
https://metraipolis.com/documento/dc_d9145697a210
How to cite
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3… — Europe PMC PMID:41257453 — Europe PMC (en), https://europepmc.org/article/MED/41257453 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9145697a210 (Metraipolis archive dc_d9145697a210, sha256 f574ef32ec98e4342ec3c6f3378abc3edcd358890a54dd3a9167a1a8a4b306b6)
BibTeX
@misc{dcd9145697a210,
title = {Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3… — Europe PMC PMID:41257453},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41257453},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9145697a210; sha256 f574ef32ec98e4342ec3c6f3378abc3edcd358890a54dd3a9167a1a8a4b306b6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41257453. Agents can read the archived copy with the MCP tool read_document.